# GRK1

## Overview
GRK1, or G protein-coupled receptor kinase 1, is a gene that encodes a serine/threonine protein kinase involved in the visual phototransduction pathway. The protein product of GRK1 plays a pivotal role in the desensitization of photoreceptor cells by phosphorylating light-activated rhodopsin, a G protein-coupled receptor (GPCR) in the retina. This phosphorylation is crucial for the deactivation of rhodopsin, facilitating the binding of arrestin-1, which prevents further activation of the phototransduction cascade. GRK1 is predominantly active in rod cells, ensuring rapid signal termination and adaptation to changing light conditions. Mutations in the GRK1 gene are linked to Oguchi disease, a form of retinitis pigmentosa characterized by night blindness and prolonged dark adaptation (Cideciyan1998Null; Whitcomb2010Effect; Bayburt2011Monomeric).

## Structure
The GRK1 protein, a serine/threonine protein kinase, is essential for the phosphorylation of rhodopsin, a process crucial for the desensitization of photoreceptor cells in the retina. The molecular structure of GRK1 includes several key domains. The central catalytic domain, known as the AGC protein kinase domain, is responsible for binding ATP and the polypeptide substrate necessary for phosphorylation. This domain is embedded within a regulator of G protein signaling homology (RH) domain, which is critical for receptor binding (Poulter2020New).

The N-terminus of GRK1 features a short alpha-helical domain, while the C-terminus contains a lipid-binding region essential for prenylation-dependent docking into the outer segment membranes of rod photoreceptors. This prenylation is crucial for the protein's localization and interaction with activated rhodopsin (Poulter2020New).

Pathogenic variants, particularly missense variants, are often located within the protein kinase domain, affecting the phosphorylation of light-activated rhodopsin. These variants can disrupt the shape and charge of the active site, impacting the protein's function (Poulter2020New). The study of GRK1 also involves understanding the effects of these variants on the protein's structure and function, using bioinformatics tools to predict pathogenicity (Poulter2020New).

## Function
GRK1, or G protein-coupled receptor kinase 1, is an enzyme that plays a critical role in the visual process by phosphorylating light-activated rhodopsin, a G protein-coupled receptor (GPCR) in the retina. This phosphorylation is essential for the deactivation of rhodopsin, allowing the visual signal to be terminated and the photoreceptor cells to reset to their dark state, ready to respond to new light stimuli (Whitcomb2010Effect). GRK1 achieves this by facilitating the binding of arrestin-1 to phosphorylated rhodopsin, which blocks further activation of transducin, a G protein involved in the phototransduction cascade (Bayburt2011Monomeric).

The enzyme is primarily active in the rod cells of the retina, where it ensures rapid and reproducible signal shut-off, crucial for visual adaptation to varying light conditions (Bayburt2011Monomeric). The RH domain of GRK1 is a major mediator of its interaction with rhodopsin, and the kinase domain must be in an active conformation for effective receptor phosphorylation (He2017Molecular). This process is vital for maintaining cellular homeostasis and preventing prolonged activation of opsins, which can lead to conditions such as Oguchi disease and increased susceptibility to light-induced photoreceptor cell death (Whitcomb2010Effect).

## Clinical Significance
Mutations in the GRK1 gene are associated with Oguchi disease, an autosomal recessive form of retinitis pigmentosa characterized by night blindness, prolonged dark adaptation, and abnormal light sensitivity. Patients with Oguchi disease often exhibit a golden-brown discoloration of the fundus upon light adaptation. Specific mutations in GRK1, such as homozygous deletions of exon 5 and compound heterozygote mutations like the V380D missense mutation and frameshift mutations, lead to a significant reduction in the enzymatic activity of GRK1 proteins (Métayé2005Pathophysiological; Khani1998Biochemical).

These genetic alterations impair the phosphorylation of light-activated rhodopsin, a critical process in visual function, resulting in delayed recovery of rod phototransduction and elevated rod thresholds (Cideciyan1998Null; Poulter2020New). The absence of functional GRK1 slows the recovery of sensitivity in rods, while cone phototransduction activation remains normal (Cideciyan1998Null). The disease is more prevalent among individuals of South Asian, East Asian, and Eastern European descent, with several pathogenic variants identified in these populations (Poulter2020New). Understanding these mutations provides insights into potential therapeutic strategies for restoring visual acuity by targeting rhodopsin deactivation (Poulter2020New).

## Interactions
GRK1, or G protein-coupled receptor kinase 1, interacts with several proteins, primarily focusing on its role in the desensitization of G protein-coupled receptors (GPCRs) like rhodopsin. The interaction between GRK1 and rhodopsin is mediated by the regulatory G-protein signaling homology (RH) domain of GRK1, which is the primary binding site for GPCRs. This interaction is crucial for the phosphorylation of rhodopsin, which subsequently allows arrestins to bind, blocking G-protein access and leading to receptor internalization (He2017Molecular).

The N-terminal region of GRK1, although not necessary for receptor binding, is essential for receptor phosphorylation. This region modulates interdomain contacts and contributes to the kinase's active conformation (He2017Molecular; Orban2012SubstrateInduced). The presence of substrates such as Mg2+•ATP and activated rhodopsin (Rho*) reduces the flexibility of GRK1, indicating a more rigid structure upon binding, which is crucial for its function in visual processes (Orban2012SubstrateInduced).

Mutations in specific residues of GRK1, such as those in the RH domain, can significantly affect its interaction with rhodopsin. For instance, mutations in helix 8 of rhodopsin severely inhibit its interaction with GRK1 (He2017Molecular). These interactions and structural dynamics are vital for the proper functioning of GRK1 in visual signal transduction.


## References


[1. (He2017Molecular) Yuanzheng He, Xiang Gao, Devrishi Goswami, Li Hou, Kuntal Pal, Yanting Yin, Gongpu Zhao, Oliver P Ernst, Patrick Griffin, Karsten Melcher, and H Eric Xu. Molecular assembly of rhodopsin with g protein-coupled receptor kinases. Cell Research, 27(6):728–747, May 2017. URL: http://dx.doi.org/10.1038/cr.2017.72, doi:10.1038/cr.2017.72. This article has 42 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/cr.2017.72)

[2. (Whitcomb2010Effect) Tiffany Whitcomb, Keisuke Sakurai, Bruce M. Brown, Joyce E. Young, Lowell Sheflin, Cynthia Dlugos, Cheryl M. Craft, Vladimir J. Kefalov, and Shahrokh C. Khani. Effect of g protein–coupled receptor kinase 1 (grk1) overexpression on rod photoreceptor cell viability. Investigative Opthalmology &amp; Visual Science, 51(3):1728, March 2010. URL: http://dx.doi.org/10.1167/iovs.09-4499, doi:10.1167/iovs.09-4499. This article has 12 citations.](https://doi.org/10.1167/iovs.09-4499)

[3. (Orban2012SubstrateInduced) Tivadar Orban, Chih-chin Huang, Kristoff T. Homan, Beata Jastrzebska, John J. G. Tesmer, and Krzysztof Palczewski. Substrate-induced changes in the dynamics of rhodopsin kinase (g protein-coupled receptor kinase 1). Biochemistry, 51(16):3404–3411, April 2012. URL: http://dx.doi.org/10.1021/bi300295y, doi:10.1021/bi300295y. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi300295y)

[4. (Cideciyan1998Null) Artur V. Cideciyan, Xinyu Zhao, Lori Nielsen, Shahrokh C. Khani, Samuel G. Jacobson, and Krzysztof Palczewski. Null mutation in the rhodopsin kinase gene slows recovery kinetics of rod and cone phototransduction in man. Proceedings of the National Academy of Sciences, 95(1):328–333, January 1998. URL: http://dx.doi.org/10.1073/pnas.95.1.328, doi:10.1073/pnas.95.1.328. This article has 120 citations.](https://doi.org/10.1073/pnas.95.1.328)

[5. (Métayé2005Pathophysiological) Thierry Métayé, Hélène Gibelin, Rémy Perdrisot, and Jean-Louis Kraimps. Pathophysiological roles of g-protein-coupled receptor kinases. Cellular Signalling, 17(8):917–928, August 2005. URL: http://dx.doi.org/10.1016/j.cellsig.2005.01.002, doi:10.1016/j.cellsig.2005.01.002. This article has 110 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cellsig.2005.01.002)

6. (Poulter2020New) New pathogenic variants and insights into pathogenic mechanisms in GRK1-related Oguchi disease. This article has 0 citations.

[7. (Bayburt2011Monomeric) Timothy H. Bayburt, Sergey A. Vishnivetskiy, Mark A. McLean, Takefumi Morizumi, Chih-chin Huang, John J.G. Tesmer, Oliver P. Ernst, Stephen G. Sligar, and Vsevolod V. Gurevich. Monomeric rhodopsin is sufficient for normal rhodopsin kinase (grk1) phosphorylation and arrestin-1 binding. Journal of Biological Chemistry, 286(2):1420–1428, January 2011. URL: http://dx.doi.org/10.1074/jbc.M110.151043, doi:10.1074/jbc.m110.151043. This article has 243 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M110.151043)

[8. (Khani1998Biochemical) Shahrokh C. Khani, Lori Nielsen, and Todd M. Vogt. Biochemical evidence for pathogenicity of rhodopsin kinase mutations correlated with the oguchi form of congenital stationary night blindness. Proceedings of the National Academy of Sciences, 95(6):2824–2827, March 1998. URL: http://dx.doi.org/10.1073/pnas.95.6.2824, doi:10.1073/pnas.95.6.2824. This article has 24 citations.](https://doi.org/10.1073/pnas.95.6.2824)